Background:Patient reported outcome measure (PROMS) and experience measures (PREMS) are becoming of vital importance in the assemment of treating the rheumatic diseases. There have been a variety measuring different elements of a patients disease journey. To date few have been developed specifically in rheumatology outpatients, to that end the Burton rheumatology unit in the Midlands UK developed a 12 question PROM looking at the three domains of emotional, physical and functional health, this has been mindful of previois PROMS and PREMS developed1,2,3.Objectives:To validate a new PROM questionnaire in an unselected group of rheumatology outpatients with osteoarthritiss (OA)Methods:Consecutive patients with OA attending outpatients in Burton were asked to fill in the questionnaire at the beginning and after completing education and exercise programme designed by the physiotherapists to treat OA. The results collated were analysed using STATA ™. Cronbach’s alpha was calculated to look internal validity within domain and overall to assess validity of the questionannire. This was done within domain and with the overall questionnaire.Results:130 patients were included, mean age was 65 and diagnosis was osteoarthritis. 71.5% patients were female. Cronbachs alpha results for the communication, relationship and reliability within the first domain were 0.80, 0.82 and 0.82 respectively. Domain 1: alpha for all three questions was 0.93. Domain 2: alpha for questions on knowledge was 0.60, reliability 0.81, fatigue 0.79 and pain 0.85. Domain two overall agreed with the other two domains was 0.95 . Domain 3: the alpha for movement was 0.81, strength was 0.73, independence was 0.81, mobility was 0.91 and social was 0.92. Domain three had an alpha overall of 0.93Conclusion:The B-PROM shows good validity and could be used in patients with OA, further work using it on other patient groups will be performed.References:[1]Nutland H et al.A New Patient Reported Tool in The Assessment of Physiotherapy for Patients with Knee Osteoarthritis. doi.org/10.1136/annrheumdis-2016-eular.5926[2]Nisar M et al. Development of A Patient Reported Self-Assessment Tool for Rheumatology Patients. doi.org/10.1136/annrheumdis-2016-eular.4670[3]Bosworth A, Cox M, O’Brien A, Jones P, Sargeant I, Elliott A, Bukhari M. Development and validation of a Patient Reported Experience Measure (PREM) for patients with rheumatoid arthritis (RA) and other rheumatic conditions.Curr Rheumatol Rev. 2015 May 21. Clinical Rheumatology. February 2016, Volume 35, Issue 2, pp 513-516Disclosure of Interests:Ramasharan Laxminarayan Speakers bureau: Novartis, Pfizer and Lilly, Allison Dean: None declared, Helen Nutland: None declared, Lisa Bembridge: None declared, Marwan Bukhari Speakers bureau: Bristol-Myers Squib, UCB celltech, Roche/Chugai, Pfizer, Abbvie, Merck, Mennarini, Sanofi-aventis, Eli-Lilly, Janssen, Amgen and Novartis.